Top

Diabetologia

Published in:

Open Access 01-03-2012 | Article

Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets

Authors: C. Dai, M. Brissova, Y. Hang, C. Thompson, G. Poffenberger, A. Shostak, Z. Chen, R. Stein, A. C. Powers

Published in: Diabetologia | Issue 3/2012

Abstract

Aims/hypothesis

Our understanding of the transcription factors that control the development and function of rodent islet beta cells is advancing rapidly, yet less is known of the role they play in similar processes in human islets.

Methods

To characterise the abundance and regulation of key proteins involved in glucose-regulated insulin secretion in human islets, we examined the expression of MAFA, MAFB, GLUT2 (also known as SLC2A2), βGK (also known as GCK) and PDX1 in isolated, highly purified human islets with an intact insulin secretory pattern. We also assessed these features in islets from two different mouse strains (C57BL/6J and FVB).

Results

Compared with mouse islets, human islets secreted more insulin at baseline glucose (5.6 mmol/l), but less upon stimulation with high glucose (16.7 mmol/l) or high glucose plus 3-isobutyl-1-methyl-xanthine. Human islets had relatively more MAFB than PDX1 mRNA, while mouse islets had relatively more Pdx1 than Mafb mRNA. However, v-maf musculoaponeurotic fibrosarcoma oncogene homologue (MAF) B protein was found in human islet alpha and beta cells. This is unusual as this regulator is only produced in islet alpha cells in adult mice. The expression of insulin, MAFA, βGK and PDX1 was not glucose-regulated in human islets with an intact insulin secretory pattern.

Conclusions/interpretation

Our results suggest that human islets have a distinctive distribution and function of key regulators of the glucose-stimulated insulin secretion pathway, emphasising the urgent need to understand the processes that regulate human islet beta cell function.

Available only for authorised users

Groop L, Lyssenko V (2008) Genes and type 2 diabetes mellitus. Curr Diab Rep 8:192–197PubMedCrossRef

Bonnefond A, Froguel P, Vaxillaire M (2010) The emerging genetics of type 2 diabetes. Trends Mol Med 16:407–416PubMedCrossRef

Brissova M, Fowler MJ, Nicholson WE et al (2005) Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 53:1087–1097PubMedCrossRef

Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103:2334–2339PubMedCrossRef

Henquin JC, Dufrane D, Nenquin M (2006) Nutrient control of insulin secretion in isolated normal human islets. Diabetes 55:3470–3477PubMedCrossRef

Henquin JC, Nenquin M, Stiernet P, Ahren B (2006) In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells. Diabetes 55:441–451PubMedCrossRef

Matschinsky FM (1996) A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45:223–241PubMedCrossRef

Matschinsky FM, Glaser B, Magnuson MA (1998) Pancreatic beta cell glucokinase. Closing the gap between theoretical concepts and experimental realities. Diabetes 47:307–315PubMedCrossRef

Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRef

10.

Tyrberg B, Andersson A, Borg LA (2001) Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan. Gen Comp Endocrinol 122:238–251PubMedCrossRef

11.

Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci U S A 91:9253–9256PubMedCrossRef

12.

Butler PC, Meier JJ, Butler AE, Bhushan A (2007) The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 3:758–768PubMedCrossRef

13.

Bosco D, Armanet M, Morel P et al (2010) Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 59:1202–1210PubMedCrossRef

14.

Ackermann AM, Gannon M (2007) Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol 38:193–206PubMedCrossRef

15.

Oliver-Krasinski JM, Stoffers DA (2008) On the origin of the beta cell. Genes Dev 22:1998–2021PubMedCrossRef

16.

Vaxillaire M, Froguel P (2008) Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 29:254–264PubMedCrossRef

17.

Stoffers DA, Ferrer J, Clarke WL, Habener JF (1997) Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138–139PubMedCrossRef

18.

Clocquet AR, Egan JM, Stoffers DA et al (2000) Impaired insulin secretion and increased insulin sensitivity in familial Maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene). Diabetes 49:1856–1864PubMedCrossRef

19.

Brissova M, Shiota M, Nicholson W et al (2002) Reduction in transcription factor pdx-1 impairs normal glucose sensing and insulin secretion by pancreatic islets. J Biol Chem 277:11225–11232PubMedCrossRef

20.

Johnson JD, Ahmed NT, Luciani DS et al (2003) Increased islet apoptosis in Pdx1+/− mice. J Clin Invest 111:1147–1160PubMed

21.

Zhang C, Moriguchi T, Kajihara M et al (2005) MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol 25:4969–4976PubMedCrossRef

22.

Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF (1997) Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF-1 gene coding sequence. Nat Genet 15:106–110PubMedCrossRef

23.

Artner I, Blanchi B, Raum JC et al (2007) MafB is required for islet beta cell maturation. Proc Natl Acad Sci U S A 104:3853–3858PubMedCrossRef

24.

Marshak S, Totary H, Cerasi E, Melloul D (1996) Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci U S A 93:15057–15062PubMedCrossRef

25.

Olbrot M, Rud J, Moss LG, Sharma A (2002) Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci U S A 99:6737–6742PubMedCrossRef

26.

Artner I, Le Lay J, Hang Y et al (2006) MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 55:297–304PubMedCrossRef

27.

Nishimura W, Kondo T, Salameh T et al (2006) A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev Biol 293:526–539PubMedCrossRef

28.

Offield MF, Jetton TL, Labosky PA et al (1996) PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983–995PubMed

29.

Jonsson J, Carlsson L, Edlund T, Edlund H (1994) Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606–609PubMedCrossRef

30.

Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M, Handa H (2002) MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J Biol Chem 277:49903–49910PubMedCrossRef

31.

Matsuoka TA, Artner I, Henderson E, Means A, Sander M, Stein R (2004) The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci U S A 101:2930–2933PubMedCrossRef

32.

Brissova M, Fowler MJ, Wiebe P et al (2004) Intra-islet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 53:1318–1325PubMedCrossRef

33.

Kaddis JS, Olack BJ, Sowinski J, Cravens J, Contreras JL, Niland JC (2009) Human pancreatic islets and diabetes research. JAMA 301:1580–1587PubMedCrossRef

34.

Ricordi C, Gray DWR, Hering BJ et al (1990) Islet isolation assessment in man and large animals. Acta Diabetol 27:185–195CrossRef

35.

Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622PubMedCrossRef

36.

Zhao L, Guo M, Matsuoka TA et al (2005) The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem 280:11887–11894PubMedCrossRef

37.

De Vos A, Heimberg H, Quartier E et al (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489–2495PubMedCrossRef

38.

Ferrer J, Benito C, Gomis R (1995) Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes 44:1369–1374PubMedCrossRef

39.

Hou X, Ling Z, Quartier E et al (1999) Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors. Diabetologia 42:188–194PubMedCrossRef

40.

Keller DM, McWeeney S, Arsenlis A et al (2007) Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem 282:32084–32092PubMedCrossRef

41.

Artner I, Hang Y, Mazur M et al (2010) MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes 59:2530–2539PubMedCrossRef

42.

Ling Z, Pipeleers DG (1996) Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98:2805–2812PubMedCrossRef

43.

Matschinsky FM, Magnuson MA, Zelent D et al (2006) The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55:1–12PubMedCrossRef

44.

Davalli AM, Ogawa Y, Scaglia L et al (1995) Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44:104–111PubMedCrossRef

45.

Braun M, Ramracheya R, Bengtsson M et al (2008) Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes 57:1618–1628PubMedCrossRef

46.

Serre-Beinier V, Bosco D, Zulianello L et al (2009) Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression. Hum Mol Genet 18:428–439PubMedCrossRef

47.

Raum JC, Hunter CS, Artner I et al (2010) Islet beta-cell-specific MafA transcription requires the 5′-flanking conserved region 3 control domain. Mol Cell Biol 30:4234–4244PubMedCrossRef

48.

Elrick LJ, Docherty K (2001) Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1. Diabetes 50:2244–2252PubMedCrossRef

49.

Rafiq I, Kennedy HJ, Rutter GA (1998) Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 beta-cells. J Biol Chem 273:23241–23247PubMedCrossRef

50.

Macfarlane WM, McKinnon CM, Felton-Edkins ZA, Cragg H, James RF, Docherty K (1999) Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells. J Biol Chem 274:1011–1016PubMedCrossRef

Title: Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets
Authors: C. Dai
M. Brissova
Y. Hang
C. Thompson
G. Poffenberger
A. Shostak
Z. Chen
R. Stein
A. C. Powers
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 3/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-011-2369-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 3/2012

Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes

INS GFP/w human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells

Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology

Erratum to: Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes

Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study

What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page